GFM
IMCR icon

GF Fund Management’s Immunocore IMCR Stock Holding History

GF Fund Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.5K Buy
980
+123
+14% +$3.98K ﹤0.01% 457
2025
Q4 		$29.7K Sell
857
-5
-0.6% -$177 ﹤0.01% 457
2025
Q3 		$31.3K Sell
862
-152
-15% -$5.16K ﹤0.01% 438
2025
Q2 		$31.8K Hold
1,014
– – ﹤0.01% 452
2025
Q1 		$30.1K Buy
1,014
+183
+22% +$5.49K ﹤0.01% 458
2024
Q4 		$24.5K Buy
+831
New +$26.3K ﹤0.01% 454

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

GF Fund Management's IMCR Position: Q1 2026 in Review

GF Fund Management increased its Immunocore (IMCR) stake by 14% in Q1 2026, buying an estimated $3.98K and bringing the position to 980 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

GF Fund Management first reported a position in IMCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $31.8K in Q2 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • GF Fund Management held 980 shares of Immunocore worth $29.5K as of Q1 2026.
  • GF Fund Management bought 123 Immunocore shares in Q1 2026, an estimated $3.98K.
  • Immunocore made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #457 holding.
  • GF Fund Management first reported a position in Immunocore in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Immunocore position peaked at $31.8K in Q2 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.